Open Access

[Corrigendum] Plasma‑derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells

  • Authors:
    • Lifei Yang
    • Shutao Zheng
    • Qing Liu
    • Tao Liu
    • Qiqi Zhang
    • Xiujuan Han
    • Aerziguli Tuerxun
    • Xiaomei Lu
  • View Affiliations

  • Published online on: January 4, 2022     https://doi.org/10.3892/or.2022.8256
  • Article Number: 45
  • Copyright : © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

March-2022
Volume 47 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yang L, Zheng S, Liu Q, Liu T, Zhang Q, Han X, Tuerxun A and Lu X: [Corrigendum] Plasma‑derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells. Oncol Rep 47: 45, 2022
APA
Yang, L., Zheng, S., Liu, Q., Liu, T., Zhang, Q., Han, X. ... Lu, X. (2022). [Corrigendum] Plasma‑derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells. Oncology Reports, 47, 45. https://doi.org/10.3892/or.2022.8256
MLA
Yang, L., Zheng, S., Liu, Q., Liu, T., Zhang, Q., Han, X., Tuerxun, A., Lu, X."[Corrigendum] Plasma‑derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells". Oncology Reports 47.3 (2022): 45.
Chicago
Yang, L., Zheng, S., Liu, Q., Liu, T., Zhang, Q., Han, X., Tuerxun, A., Lu, X."[Corrigendum] Plasma‑derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells". Oncology Reports 47, no. 3 (2022): 45. https://doi.org/10.3892/or.2022.8256